Wang Ying, Thaler Melissa, Salgado-Benvindo Clarisse, Ly Nathan, Leijs Anouk A, Ninaber Dennis K, Hansbro Philip M, Boedijono Fia, van Hemert Martijn J, Hiemstra Pieter S, van der Does Anne M, Faiz Alen
PulmoScience Lab, Department of Pulmonology Leiden University Medical Center Leiden The Netherlands.
Department of Medical Microbiology Leiden University Medical Center Leiden The Netherlands.
Clin Transl Immunology. 2024 Apr 15;13(4):e1503. doi: 10.1002/cti2.1503. eCollection 2024.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of a class of highly pathogenic coronaviruses. The large family of coronaviruses, however, also includes members that cause only mild symptoms, like human coronavirus-229E (HCoV-229E) or OC43 (HCoV-OC43). Unravelling how molecular (and cellular) pathophysiology differs between highly and low pathogenic coronaviruses is important for the development of therapeutic strategies.
Here, we analysed the transcriptome of primary human bronchial epithelial cells (PBEC), differentiated at the air-liquid interface (ALI) after infection with SARS-CoV-2, SARS-CoV, Middle East Respiratory Syndrome (MERS)-CoV and HCoV-229E using bulk RNA sequencing.
ALI-PBEC were efficiently infected by all viruses, and SARS-CoV, MERS-CoV and HCoV-229E infection resulted in a largely similar transcriptional response. The response to SARS-CoV-2 infection differed markedly as it uniquely lacked the increase in expression of immediate early genes, including , and that was observed with all other coronaviruses. This finding was further confirmed in publicly available experimental and clinical datasets. Interfering with NR4A1 signalling in Calu-3 lung epithelial cells resulted in a 100-fold reduction in extracellular RNA copies of SARS-CoV-2 and MERS-CoV, suggesting an involvement in virus replication. Furthermore, a lack in induction of interferon-related gene expression characterised the main difference between the highly pathogenic coronaviruses and low pathogenic viruses HCoV-229E and HCoV-OC43.
Our results demonstrate a previously unknown suppression of a host response gene set by SARS-CoV-2 and confirm a difference in interferon-related gene expression between highly pathogenic and low pathogenic coronaviruses.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一类高致病性冠状病毒的成员。然而,庞大的冠状病毒家族中也包括一些只会引起轻微症状的成员,如人类冠状病毒229E(HCoV-229E)或OC43(HCoV-OC43)。阐明高致病性和低致病性冠状病毒在分子(和细胞)病理生理学上的差异对于治疗策略的开发很重要。
在此,我们使用批量RNA测序分析了原代人支气管上皮细胞(PBEC)在气液界面(ALI)分化后感染SARS-CoV-2、SARS-CoV、中东呼吸综合征(MERS)-CoV和HCoV-229E后的转录组。
ALI-PBEC被所有病毒有效感染,SARS-CoV、MERS-CoV和HCoV-229E感染导致了大致相似的转录反应。对SARS-CoV-2感染的反应明显不同,因为它独特地缺乏包括 、 和 在内的立即早期基因表达的增加,而所有其他冠状病毒感染时都观察到了这种增加。这一发现在公开可用的实验和临床数据集中得到了进一步证实。干扰Calu-3肺上皮细胞中的NR4A1信号传导导致SARS-CoV-2和MERS-CoV的细胞外RNA拷贝数减少100倍,表明其参与病毒复制。此外,高致病性冠状病毒与低致病性病毒HCoV-229E和HCoV-OC43之间的主要区别在于缺乏干扰素相关基因表达的诱导。
我们的结果证明了SARS-CoV-2对宿主反应基因集的一种前所未知的抑制作用,并证实了高致病性和低致病性冠状病毒在干扰素相关基因表达上的差异。